Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke

Status: Recruiting
Location: See location...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a randomized control trial that will evaluate the effectiveness of transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals with hemiplegia due to stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age 18 or older

• Able and willing to give written consent and comply with study procedures

• Participants are 18 years of age or older

• Participants are at least 4 weeks post stroke

• Participants with hemiplegia secondary to a single stroke

• Functional Ambulation Category of 2 or greater - Patient needs continuous or intermittent support of one person to help with balance and coordination.

• Participants are able to provide informed consent

• Participants are not currently receiving regular physical therapy services

Locations
United States
Illinois
Shirley Ryan AbilityLab
RECRUITING
Chicago
Contact Information
Primary
Kelly McKenzie, DPT
kaskins@sralab.org
312-238-7111
Backup
Lori l McGee, BS, OT
lmcgee@sralab.org
312-238-2091
Time Frame
Start Date: 2018-08-17
Estimated Completion Date: 2022-12-31
Participants
Target number of participants: 90
Treatments
Experimental: Noninvasive Spinal Stimulation with Gait Training
May receive up to 50 min of locomotion training with transcutaneous spinal cord stimulation. However, the amount of time spent in side-lying locomotion training, treadmill training and overground training will depend on individual tolerance and progression.
Active_comparator: Conventional Gait Training
May receive up to 50 min of locomotion training without transcutaneous spinal cord stimulation. However, the amount of time spent in side-lying locomotion training, treadmill training and overground training will depend on individual tolerance and progression.
Other: Healthy Control Group
Participant in the Healthy Control Group will participate in up to 3 assessment sessions in order to obtain comparative data for Spinal Motor Evoked Potentials (MEPs), lower extremity MVC's, sidelying EMG data and overground EMG data
Sponsors
Leads: Shirley Ryan AbilityLab
Collaborators: University of California, Los Angeles

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.